Media releaseFrom: Australian Science Media Centre
*Briefing recording now available*
Is the world prepared for a wave of neurological consequences that may be on its way as a result of COVID-19? This question is at the forefront of research underway at the Florey Institute of Neuroscience and Mental Health. A team of neuroscientists and clinicians are examining the potential link between COVID-19 and increased risk of Parkinson’s disease, and measures to get ahead of the curve. In a review paper to be published on Wednesday, researchers have put the spotlight on the potential long-term neurological consequences of COVID-19, dubbing it the ‘silent wave’.
Join us for this online briefing as they call for urgent action to be taken to have available more accurate diagnostic tools to identify neurodegeneration early on, advance neuroprotective treatments underway and establish long-term monitoring of people who have been infected with the SARS-CoV-2 virus.
The briefing will discuss the following issues:
- Proposed link between SARS-CoV-2 virus and Parkinson’s disease
- National screening proposal for earlier diagnosis of Parkinson’s disease
- Development of neuroprotective therapies underway
- Leah Beauchamp is a PhD Candidate in the Neurotherapeutics Laboratory at the Florey Institute of Neuroscience and Mental Health
- Professor Kevin Barnham is Head of the Neurotherapeutics Laboratory at the Florey Institute of Neuroscience and Mental Health
Date: Tue 22 Sep 2020
Start Time: 11:00am AEST
Duration: 30 mins